2022
DOI: 10.1002/brb3.2746
|View full text |Cite
|
Sign up to set email alerts
|

Cortical gray matter microstructural alterations in patients with type 2 diabetes mellitus

Abstract: Background and purpose Neurodegenerative processes are widespread in the brains of type 2 diabetes mellitus (T2DM) patients; gaps remain to exist in the current knowledge of the associated gray matter (GM) microstructural alterations. Methods A cross‐sectional study was conducted to investigate alterations in GM microarchitecture in T2DM patients by diffusion tensor imaging and neurite orientation dispersion and density imaging (NODDI). Seventy‐eight T2DM patients and s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
0
1
0
Order By: Relevance
“…Diabetes, in particular, is a widespread epidemic that affects more than 425 million people worldwide (Adams et al, 2021 ) with type 2 diabetes (T2D) accounting for 90% of diabetes cases globally (Huang et al, 2022 ). Both type 1 and type 2 diabetes result in adverse effects not only for the pancreas but also the liver, kidneys, muscle, fat cells, and, as is now increasingly understood, the brain (Stephen Brunton, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes, in particular, is a widespread epidemic that affects more than 425 million people worldwide (Adams et al, 2021 ) with type 2 diabetes (T2D) accounting for 90% of diabetes cases globally (Huang et al, 2022 ). Both type 1 and type 2 diabetes result in adverse effects not only for the pancreas but also the liver, kidneys, muscle, fat cells, and, as is now increasingly understood, the brain (Stephen Brunton, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disease with an increasing worldwide prevalence, and is known to involve many organ systems in the human body ( 1 , 2 ). The number of patients with T2DM may increase to 42.3 million by the year 2030 ( 3 ).…”
Section: Introductionmentioning
confidence: 99%